Denmark Women’s Health Market Size & Outlook, 2023-2030
Denmark women’s health market, 2018-2030 (US$M)
Related Markets
Denmark women’s health market highlights
- The Denmark women’s health market generated a revenue of USD 116.4 million in 2023 and is expected to reach USD 177.9 million by 2030.
- The Denmark market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
Women’s health market data book summary
| Market revenue in 2023 | USD 116.4 million |
| Market revenue in 2030 | USD 177.9 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, Denmark accounted for 0.3% of the global women’s health market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany women’s health market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 3,031.4 million by 2030.
Contraceptives was the largest segment with a revenue share of 33.08% in 2023. Horizon Databook has segmented the Denmark women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
The age for menopause was found to be low in women in Denmark, and about 16.7% of women experienced menopause around the age of 40 in the country. However, the average age of menopause in the remaining population ranges between 51 and 52 years.
Moreover, According to World Bank, in 2022, the female population of Denmark aged 65 and above was around 651,000 and it is expected to increase in the coming years. An increase in the geriatric population in the country is anticipated to increase the prevalence of targeted diseases such as postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, and others.
For instance, according to the International Osteoporosis Foundation, the total prevalence of osteoporosis is around 5.1% in Denmark, and female patients account for more than 77% of total osteoporosis cases in the country. Increasing collaborations among government institutes and market players to improve women’s health are expected to support market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Denmark women’s health market size, by application, 2018-2030 (US$M)
Denmark Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
